Katrine Thor Andersen, deputy director, strategy planning and management for the Tuberculosis and Global Health strategy, planning and management teams, is responsible for the team’s strategy and business operations.
Prior to joining the foundation in 2017, Katrine held senior leadership positions leading global business transformation at Global Research, Novo Nordisk. The projects that she led include organization development, operational excellence, R&D informatics, outsourcing, and portfolio management. Katrine has been engaged in drug development since 1998 and held positions across the product development value chain at Bristol Myers Squibb, Novo Nordisk, and LEO Pharma. She worked as a pharmaceutics research scientist and product project leader for 8 years, followed by working as a regulatory affairs transformation consultant, R&D outsourcing manager and R&D chief of staff. She also has experience in regulatory affairs in the public sector through her work at the Danish Medicine Agency. Katrine is passionate about innovation and has served as business strategy advisor to start-ups within eHealth and scientific IT.
Katrine holds MBA from Copenhagen Business School, an MSc Quality Assurance & Regulatory Affairs from Temple University, and an MSc Pharmacy from the Royal Danish School of Pharmacy.